Skip to content

Drug interactions

Glecaprevir / pibrentasvir + Ribociclib

Severity: Moderate

Glecaprevir / pibrentasvir and Ribociclib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glecaprevir and pibrentasvir are inhibitors of P-gp, BCRP and OATP, and ribociclib is a substrate of P-gp and BCRP. Ribociclib exposure could rise, increasing QT prolongation and neutropenia risk, while the effect of ribociclib on glecaprevir/pibrentasvir is minor.

What this interaction means in plain words

Glecaprevir / pibrentasvir and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Transporter inhibition by glecaprevir/pibrentasvir may increase ribociclib exposure, with minor CYP3A4 contribution.

What to do

Monitor ECG, electrolytes and blood counts during the short HCV course. Reduce the ribociclib dose if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glecaprevir / pibrentasvir and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Glecaprevir / pibrentasvir with Ribociclib?

MediHelp rates the interaction as moderate. Glecaprevir / pibrentasvir and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Glecaprevir and pibrentasvir are inhibitors of P-gp, BCRP and OATP, and ribociclib is a substrate of P-gp and BCRP. Ribociclib exposure could rise, increasing QT prolongation and neutropenia risk, while the effect of ribociclib on glecaprevir/pibrentasvir is minor.

How serious is the interaction between Glecaprevir / pibrentasvir and Ribociclib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG, electrolytes and blood counts during the short HCV course. Reduce the ribociclib dose if toxicity occurs.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in